Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.

Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, Schwartzbaum J, Heimberger A, Sampson JH, Chang S, Prados M, Wiencke JK, Wrensch M.

Int J Cancer. 2009 Aug 1;125(3):680-7. doi: 10.1002/ijc.24369.

2.

Reduced immunoglobulin E and allergy among adults with glioma compared with controls.

Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, Miike R, Barger G, Wrensch M.

Cancer Res. 2004 Nov 15;64(22):8468-73.

3.

Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies.

Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, Willett WC, Tworoger SS, Hunter DJ, Camargo CA Jr, Michaud DS.

J Natl Cancer Inst. 2011 Nov 2;103(21):1588-95. doi: 10.1093/jnci/djr361. Epub 2011 Oct 18.

4.

Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.

Schlehofer B, Siegmund B, Linseisen J, Schüz J, Rohrmann S, Becker S, Michaud D, Melin B, Bas Bueno-de-Mesquita H, Peeters PH, Vineis P, Tjonneland A, Olsen A, Overvad K, Romieu I, Boeing H, Aleksandrova K, Trichopoulou A, Bamia C, Lagiou P, Sacerdote C, Palli D, Panico S, Sieri S, Tumino R, Sanchez MJ, Rodriguez L, Dorronsoro M, Duell EJ, Chirlaque MD, Barricarte A, Borgquist S, Manjer J, Gallo V, Allen NE, Key TJ, Riboli E, Kaaks R, Wahrendorf J.

Allergy. 2011 Nov;66(11):1434-41. doi: 10.1111/j.1398-9995.2011.02670.x. Epub 2011 Jul 5.

5.

Association between prediagnostic IgE levels and risk of glioma.

Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK.

J Natl Cancer Inst. 2012 Aug 22;104(16):1251-9. doi: 10.1093/jnci/djs315. Epub 2012 Aug 1.

6.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

7.

Allergy-related polymorphisms influence glioma status and serum IgE levels.

Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, Miike R, Wrensch M.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1229-35.

8.

Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K.

Am J Epidemiol. 2001 Jul 15;154(2):161-5.

PMID:
11447050
9.

Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma.

Zhou M, Wiemels JL, Bracci PM, Wrensch MR, McCoy LS, Rice T, Sison JD, Patoka JS, Wiencke JK.

Cancer Res. 2010 Oct 1;70(19):7534-42. doi: 10.1158/0008-5472.CAN-10-0815. Epub 2010 Aug 18.

10.

Temozolomide and treatment of malignant glioma.

Friedman HS, Kerby T, Calvert H.

Clin Cancer Res. 2000 Jul;6(7):2585-97. Review.

11.

Increased rate of positive penicillin skin tests among patients with glioma: insights into the association between allergies and glioma risk.

Han S, Huang Y, Wang Z, Li Z, Qin X, Wu A.

J Neurosurg. 2014 Nov;121(5):1176-84. doi: 10.3171/2014.7.JNS1412. Epub 2014 Aug 29.

PMID:
25170669
12.

Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Lee ST, Bracci P, Zhou M, Rice T, Wiencke J, Wrensch M, Wiemels J.

Int J Cancer. 2014 May 1;134(9):2199-210. doi: 10.1002/ijc.28535. Epub 2013 Oct 31.

13.

History of allergies among adults with glioma and controls.

Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M.

Int J Cancer. 2002 Apr 1;98(4):609-15.

14.

Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk.

Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lönn S, Söderberg KC, Feychting M.

Int J Cancer. 2003 Sep 1;106(3):423-8. Review.

15.

Allergic conditions and brain tumor risk.

Wigertz A, Lönn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M.

Am J Epidemiol. 2007 Oct 15;166(8):941-50. Epub 2007 Jul 23.

PMID:
17646205
16.

Temozolomide in malignant gliomas: current use and future targets.

Villano JL, Seery TE, Bressler LR.

Cancer Chemother Pharmacol. 2009 Sep;64(4):647-55. doi: 10.1007/s00280-009-1050-5. Epub 2009 Jun 19. Review.

PMID:
19543728
17.
18.

History of allergies and autoimmune diseases and risk of brain tumors in adults.

Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Int J Cancer. 2002 May 10;99(2):252-9.

19.

Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Amirian ES, Marquez-Do D, Bondy ML, Scheurer ME.

Cancer Epidemiol. 2013 Dec;37(6):908-12. doi: 10.1016/j.canep.2013.08.004. Epub 2013 Aug 30.

20.

[Recent advances in the medical treatment of glioma-temozolomide].

Nishikawa R.

No To Shinkei. 2006 Dec;58(12):1035-41. Japanese. No abstract available.

PMID:
17193953

Supplemental Content

Support Center